About immunodiagnostics
Immunodiagnostics is a class of in vitro diagnostics that utilizes antigen-antibody reaction as its primary means of detecting infectious diseases, tumors, diabetes, proteins, therapeutic drugs, and allergens. Immunodiagnostics tests are analytical methods that require different immunodiagnostics instruments and antibodies as reagents against the desired antigens to be detected. The test results are used to diagnosis diseases, and they have widespread clinical applications. Immunodiagnostics tests are also helpful in the field of forensic science, environmental science, and food analysis.
The rate of chronic diseases and infections in China has increased significantly in the past few years. Therefore, there is an increase in the demand for immunodiagnostics tests to detect diseases at an early stage, driving the immunodiagnostics market in China.
Technavio's analysts forecast the immunodiagnostics market in China to grow at a CAGR of 16.6% over the period 2014-2019.
Covered in this report
The report covers the current scenario and the growth prospects of the immunodiagnostics market in China for the period of 2015-2019. To calculate the market size, the report considers revenue generated through the sales of immunodiagnostic test products. Based on technique, the market is segmented into the following:
• ELISA
• CLIA
• Others (immunofluorescent test, radio immunoassay, immunoelectrophoresis, flow cytometry, and lateral flow immunoassay)
Based on product, the market is segmented into the following:
• Reagents
• Instruments
Technavio's report, Immunodiagnostic Market in China 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the landscape of the immunodiagnostic market in China and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Key vendors
• Abbott Diagnostics
• Beckman Coulter Diagnostics
• Roche Diagnostics
• Siemens Healthcare Diagnostics
Other prominent vendors
• BioSino Bio-technology & Science
• DiaSorin
• Immunodiagnostic System Holdings (IDS)
• Mindray Medical International
• Shanghai Kehua Bio-engineering
• Sichuan Maccura Biotechnology
Key market driver
• Widening of insurance coverage
• For a full, detailed list, view our report
Key market challenge
• Declining imports
• For a full, detailed list, view our report
Key market trend
• Growing mergers and acquisitions
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
PART 01: Executive summary
Highlights
PART 02: Scope of the report
Market overview
Top-vendor offerings
PART 03: Market research methodology
Research methodology
Economic indicators
PART 04: Introduction
Key market highlights
PART 05: Insurance coverage and reimbursement in China
PART 06: Regulatory landscape
PART 07: Diagnostics distribution network in China
PART 08: Market landscape
Market overview
Market size and forecast
Five forces analysis
PART 09: Market segmentation by product
Immunodiagnostic reagents market in China
Immunodiagnostic instruments market in China
PART 10: Market segmentation by techniques
ELISA (Enzyme linked immunosorbent assay)
Chemiluminescence immunoassay
Other techniques
PART 11: Market drivers
Widening of insurance coverage
Increase in joint ventures
High prevalence of chronic diseases and infections
Government measures for improving healthcare facilities
Increasing privatization in the healthcare sector
Increase in demand due to removal of medicine mark-ups
PART 12: Impact of drivers
PART 13: Market challenges
Declining imports
Promotion of local manufacturing
Threat to protection of patents
Stringent regulatory policies
Pricing pressure through price ceilings
Uneven reimbursement policies
PART 14: Impact of drivers and challenges
PART 15: Market trends
Increase in M&A
Increasing usage of chemiluminiscence immunoassay
Increase in POC concept
Shift towards automation
PART 16: Vendor landscape
Competitive scenario
Key prominent vendors
Other prominent vendors
PART 17: Key vendor analysis
Roche Diagnostics
Abbott Diagnostics
Siemens Healthcare
Beckman Coulter
PART 18: Appendix
List of abbreviations
List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Health insurance system in China
Exhibit 03: Regulatory process for the approval of medical devices
Exhibit 04: Registration process of the IVD products in China
Exhibit 05: Diagnostics dealers for clinical institutes in China 2013
Exhibit 06: Immunodiagnostics market in China
Exhibit 07: Immunodiagnostics market in China 2014-2019 ($ billions)
Exhibit 08: Five forces analysis
Exhibit 09: Immunodiagnostics market in China by product type
Exhibit 10: Segmentation of immunodiagnostics market in China by product type 2014
Exhibit 11: Segmentation of the market by product type 2014-2019
Exhibit 12: Immunodiagnostic reagents market in China 2014-2019 ($ billions)
Exhibit 13: Immunodiagnostic instruments market in China 2014-2019 ($ billions)
Exhibit 14: Segmentation of the immunodiagnostics market in China by techniques
Exhibit 15: Immunodiagnostics market for ELISA in China 2014-2019 ($ millions)
Exhibit 16: Immunodiagnostics market for CLIA in China 2014-2019 ($ millions)
Exhibit 17: Immunodiagnostics market for other techniques in China 2014-2019 ($ millions)
Exhibit 18: Market segmentation by techniques in China 2014-2019
Exhibit 19: Impact of drivers
Exhibit 20: Impact of drivers and challenges
Exhibit 21: Roche Diagnostics: Key takeaways
Exhibit 22: Abbott Diagnostics: Key takeaways
Exhibit 23: Siemens Healthcare: Key takeaways
Exhibit 24: Beckman Coulter: Key takeaways
Exhibit 25: Abbott Diagnostics: Key business offerings
Exhibit 26: Beckman Coulter: Business segmentation
